Mobergslien Anne, Sioud Mouldy
Division of Cancer Medicine, Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway.
Methods Mol Biol. 2025;2965:479-488. doi: 10.1007/978-1-0716-4742-4_25.
Small interfering RNAs (siRNAs) hold significant promise as therapeutic agents for treating human diseases. However, their use is often limited by unintended off-target effects arising from both the sense and antisense strands. Since the 5'-phosphate group on either strand is necessary for recognition by Argonaute 2 (AGO2), the core protein in the RNA-induced silencing complex (RISC), blocking phosphorylation of the sense strand may prevent its incorporation into RISC, thereby reducing potential off-target effects. In this chapter, we describe the use of biotin, a naturally occurring compound, to block 5'-end phosphorylation on either the sense or antisense strand to prevent their selection by AGO2. This strategy should offer a practical option to enhance siRNA specificity and efficacy.
小干扰RNA(siRNA)作为治疗人类疾病的治疗剂具有巨大的前景。然而,它们的使用常常受到来自正义链和反义链的意外脱靶效应的限制。由于RNA诱导沉默复合体(RISC)的核心蛋白AGO2识别需要两条链上的5'-磷酸基团,因此阻断正义链的磷酸化可能会阻止其掺入RISC,从而减少潜在的脱靶效应。在本章中,我们描述了使用天然存在的化合物生物素来阻断正义链或反义链上的5'-末端磷酸化,以防止AGO2对它们的选择。这种策略应该为提高siRNA的特异性和功效提供一个实用的选择。